Here we used two different rodent models to show that synucleinopathy causes upregulation of three different markers of DNA damage in vivo—γH2AX, 53BP1, and p-ATM—specifically in dopaminergic neurons. The gene discussed is TP53BP1; the disease is synucleinopathy.